GSK Plc (GSK)
52.50
+0.61
(+1.18%)
USD |
NYSE |
Jun 26, 16:00
52.56
+0.06
(+0.11%)
After-Hours: 20:00
GSK Cash and Short Term Investments (Quarterly) : 4.540B for March 31, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 4.540B |
| December 31, 2025 | 4.581B |
| September 30, 2025 | 4.451B |
| June 30, 2025 | 4.959B |
| March 31, 2025 | 5.789B |
| December 31, 2024 | 4.873B |
| September 30, 2024 | 4.308B |
| June 30, 2024 | 3.771B |
| March 31, 2024 | 5.173B |
| December 31, 2023 | 6.606B |
| September 30, 2023 | 8.157B |
| June 30, 2023 | 8.269B |
| March 31, 2023 | 8.624B |
| December 31, 2022 | 9.475B |
| September 30, 2022 | 7.994B |
| June 30, 2022 | 7.933B |
| March 31, 2022 | 10.37B |
| December 31, 2021 | 5.872B |
| September 30, 2021 | 4.738B |
| June 30, 2021 | 4.921B |
| March 31, 2021 | 6.646B |
| December 31, 2020 | 8.707B |
| September 30, 2020 | 5.644B |
| June 30, 2020 | 10.20B |
| March 31, 2020 | 6.020B |
| Date | Value |
|---|---|
| December 31, 2019 | 6.340B |
| September 30, 2019 | 5.411B |
| June 30, 2019 | 5.354B |
| March 31, 2019 | 5.490B |
| December 31, 2018 | 5.041B |
| September 30, 2018 | 5.124B |
| June 30, 2018 | 5.561B |
| March 31, 2018 | 5.937B |
| December 31, 2017 | 5.383B |
| September 30, 2017 | 6.692B |
| June 30, 2017 | 5.372B |
| March 31, 2017 | 5.903B |
| December 31, 2016 | 6.354B |
| September 30, 2016 | 6.304B |
| June 30, 2016 | 7.046B |
| March 31, 2016 | 6.650B |
| December 31, 2015 | 8.888B |
| September 30, 2015 | 9.235B |
| June 30, 2015 | 12.12B |
| March 31, 2015 | 15.54B |
| December 31, 2014 | 7.099B |
| September 30, 2014 | 7.107B |
| June 30, 2014 | 5.677B |
| March 31, 2014 | 6.113B |
| December 31, 2013 | 9.532B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| AstraZeneca PLC | 7.675B |
| Johnson & Johnson | 22.05B |
| Eli Lilly & Co. | 5.282B |
| Merck & Co., Inc. | 5.773B |
| Novo Nordisk A/S | 3.335B |